99% Savings - Buy Just @1 Rs X
Arkaval CR 133 / 58 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Epilepsy. The alternative uses of Arkaval CR 133 / 58 Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Arkaval CR 133 / 58 Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Arkaval CR 133 / 58 Tablet include Loss of appetite. While these are the most often observed Arkaval CR 133 / 58 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Arkaval CR 133 / 58 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Arkaval CR 133 / 58 Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. It is important to know if Arkaval CR 133 / 58 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Arkaval CR 133 / 58 Tablet related warnings section.
Individuals suffering from medical conditions like Depression must refrain from the use of Arkaval CR 133 / 58 Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Arkaval CR 133 / 58 Tablet are listed in the contraindications section below.
Drug reaction of Arkaval CR 133 / 58 Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Arkaval CR 133 / 58 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Arkaval CR 133 / 58 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Arkaval CR 133 / 58 Tablet safe for pregnant women?
Arkaval Cr has many dangerous side effects in pregnant women. If you are pregnant, do not consume Arkaval Cr without medical advice.
Is the use of Arkaval CR 133 / 58 Tablet safe during breastfeeding?
Arkaval Cr has been seen to have minimal side effects on breastfeeding women.
What is the effect of Arkaval CR 133 / 58 Tablet on the Kidneys?
Arkaval Cr may have mild side effects on the kidneys.
What is the effect of Arkaval CR 133 / 58 Tablet on the Liver?
Arkaval Cr is rarely harmful for the liver.
What is the effect of Arkaval CR 133 / 58 Tablet on the Heart?
Using Arkaval Cr does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Arkaval CR 133 / 58 Tablet unless your doctor advises you to do so -
Is this Arkaval CR 133 / 58 Tablet habit forming or addictive?
Forming a habit of Arkaval CR 133 / 58 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Arkaval CR 133 / 58 Tablet as you may feel sleepy.
Is it safe?
Arkaval CR 133 / 58 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, Arkaval CR 133 / 58 Tablet is useful in treating mental disorders.
Interaction between Food and Arkaval CR 133 / 58 Tablet
Taking Arkaval CR 133 / 58 Tablet with food does not harm your health.
Interaction between Alcohol and Arkaval CR 133 / 58 Tablet
Consult your doctor before consuming alcohol while taking Arkaval CR 133 / 58 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1243-1245
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stavzor (valproic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)